Viruses can mutate quickly. This impedes efforts to develop lasting antiviral therapies. A study led by Kent Kirshenbaum at New York University overcomes this constraint by targeting the virus ...

Antiviral therapies are notoriously difficult to develop, as viruses can quickly mutate to become resistant to drugs. But what if a new generation of antivirals ignores the fast-mutating proteins on ...

Scientists at Harvard Medical School and Boston University Chobanian & Avedisian School of Medicine have mapped a critical component of the Nipah virus, a highly lethal bat-borne pathogen that has ...

Antiviral therapies are notoriously difficult to develop, as viruses can quickly mutate to become resistant to drugs, or hide within cells. Researchers at NYU have now developed a new approach to ...

Researchers at the Nanoscience Initiative, Advanced Science Research Center at the CUNY Graduate Center (CUNY ASRC) have made what they describe as a breakthrough in the fight against viral diseases, ...

Picolinic acid, a natural compound produced by mammalian cells, can block several disease-causing viruses such as SARS-CoV-2 and influenza A viruses, according to a new study by researchers at the ...